Alcon

ALC Healthcare Medical Instruments & Supplies

Alcon’s revenue for fiscal 2025 (year ended December 2025) was $10.4 billion, up 4.94% from fiscal 2024.

Revenue
+8.74%
EPS
−100.0%
Free cash flow
−0.54%
Total debt
−0.55%

Quarter to June 2026, against a year earlier

74.54 2.01 −2.63%
Market cap
$36.9B
P/E
58.4×
Fwd P/E
44.5×
Dividend yield
0.46%
F-score
6/9
Altman Z
n/a
Beneish M
−2.56
Dividend safety
66/100

Alcon (ALC) P/B ratio

Alert me on P/B ratio

As of 5 November 2026, Alcon (ALC) trades at a P/B ratio of 1.7×. Over the past ten years it has ranged from 1.0× (March 2020) to 2.4× (September 2024); the current reading is higher than 39% of that period. That is below the Medical Instruments & Supplies industry median of 2.3× and below the Healthcare sector median of 2.3×.

P/B ratio, daily

Embed this chart

Annual newest first

Period P/B ratio Change
FY2025 1.8× (9.41%)
FY2024 1.9× 5.74%
FY2023 1.8× 6.90%
FY2022 1.7× (22.29%)
FY2021 2.2× 29.33%
FY2020 1.7× 19.82%
FY2019 1.4× 14.31%
FY2018 1.3× 0.00%
FY2017 1.3× 0.00%
FY2016 1.3× —

Quarterly newest first

Period P/B ratio Change
Jun 2026 1.5× (8.83%)
Mar 2026 1.7× (5.98%)
Dec 2025 1.8× 6.03%
Sep 2025 1.7× (15.78%)
28 more quarters

Against its own ten years

Low 1.0× High 2.4×
Ten-year median 1.8×
Current reading's percentile 39

P/B ratio against peers

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on ALC